Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TRY 238.21 million compared to TRY 468.38 million a year ago. Net loss was TRY 136.67 million compared to TRY 21.06 million a year ago.
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret
Equities
ANGEN
TREANGN00028
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.2 TRY | +1.24% | -0.89% | -2.01% |
1st Jan change | Capi. | |
---|---|---|
-2.01% | 82.34M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- ANGEN Stock
- News Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret
- Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2023